Hyperoside has been shown to inhibit the proliferation of A549 non-small cell lung carcinoma cells by triggering mitochondrial apoptosis, with caspase activation and modulation of signaling pathways such as JNK and p38 MAPK [23]. Here, MAPK8 is linked to non-small cell lung carcinoma.